Results 101 to 110 of about 12,110 (254)

A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder

Brain Sciences
Objective: This study aims to provide an overview of pharmacological trials that examine the neurocognitive effects of psychedelics among healthy individuals and patients with post-traumatic stress disorder (PTSD) or major depressive disorder (MDD ...
Mario Renato Velit-Salazar, Paulo R. Shiroma, Eloise Cherian   +2 more
doaj   +1 more source

Ocular sequelae from the illicit use of class A drugs [PDF]

, 2004
Aim: To highlight the changes that may take place in the visual system of the class A drug abuser. Methods: A literature review was carried out of ocular/visual sequelae of the more common class A drugs.
Firth, A.Y.
core  

Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders

Pharmaceuticals
Psychedelics have recently (re)emerged as therapeutics of high potential for multiple mental health conditions, including substance use disorders (SUDs).
Tamara Valdez, Valbhi Patel, Nattaphone Senesombath, Zayd Hatahet-Donovan, Mary Hornick   +4 more
doaj   +1 more source

Pharmacology of novel psychoactive substances [PDF]

, 2016
This PhD work consists of an in vitro and in vivo part. In the in vivo part, we investigated the role of dopamine in the acute clinical effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in healthy human subjects.
Rickli, Anna
core   +1 more source

Psychedelics as a potential treatment for tobacco use disorder: a systematic review

Discover Mental Health
Introduction Despite considerable efforts, tobacco use disorder persists as a significant public health issue. The effectiveness of current smoking cessation therapies is limited, leading to a growing interest in alternative treatment approaches such as ...
S. K. Spoelstra, R. A. Schoevers, S. D. Venema, H. Knegtering   +3 more
doaj   +1 more source

Treatment of neuropathic pain with repeated low-dose MDMA: a case report

Frontiers in Psychiatry
A 64-year-old male patient who suffered from traumatic life experiences and neuropathic pain after oncological chemotherapy was treated with medium to high doses of lysergic acid diethylamide (LSD) and high doses and microdoses of ...
Peter Gasser, Matthias E. Liechti, Friederike Holze   +2 more
doaj   +1 more source

Safety pharmacology of acute MDMA administration in healthy subjects [PDF]

, 2017
3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) is being investigated in MDMA-assisted psychotherapy. The present study characterized the safety pharmacology of single-dose administrations of MDMA (75 or 125 mg) using data from nine double-blind ...
Liechti, Matthias E., Vizeli, Patrick
core   +1 more source

Club drugs: Um Novo Perfil de Abuso de Substâncias em Adolescentes e Jovens Adultos.

Acta Médica Portuguesa, 2011
Club drugs are the following substances: Methylenedioxymethamphetamine (MDMA); Methamphetamine; Lysergic Acid Diethylamide (LSD); Ketamine; Gamma-hydroxybutyrate (GHB) and Flunitrazepam.
Diogo Frasquilho Guerreiro, Ana Lisa Carmo, Joaquim Alves da Silva, Rita Navarro, Carlos Góis   +4 more
doaj   +1 more source

The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules

Cell Reports
Summary: Increasing global concerns about psychoactive substance addiction and psychotic disorders highlight the need for comprehensive research into the structure-function relationship governing ligand recognition between these substances and their ...
Kexin Jiang, You Zheng, Liting Zeng, Ling Wang, Fei Li, Jun Pu, Yingli Lu, Suwen Zhao, Fei Xu   +8 more
doaj   +1 more source

The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide. [PDF]

, 1991
W. M. H. Behan, A. M. O. Bakheit, Peter O. Behan, I. A. R. More   +3 more
openalex   +1 more source